EquiCeutica Clinical & Global Standards
Contact
Veterinary Endorsements, SAIFX™ Liposomal Technology & Global Standards
EquiCeutica utilizes proprietary SAIFX™ nano-liposomal delivery technology (85–90% phosphatidylcholine) validated by Professor Mohammad Najlah (Professor of Pharmaceutics and Nano-Medicines, Anglia Ruskin University). Classified as a Prescription Only "Special" Veterinary Medicine (POM-V) in the UK, EU, and Australia, and prescribed by over 50 leading veterinary hospitals including Rossdales Equine Hospital, B&W Equine Group, and Via Nova Equine Clinic.
These statements have not been evaluated by the FDA. Our products are not intended to diagnose, treat, cure or prevent any disease.